Impact of in-sewer transformation on 43 pharmaceuticals in a pressurized sewer under anaerobic conditions

Water Research

Volumn 68, Issue , 2015, Pages 98-108

  Jelic, Aleksandra ^a   Rodriguez Mozaz, Sara ^a   Barceló, Damia ^a,b   Gutierrez, Oriol ^a  

^a UNIVERSITY OF GIRONA   (Spain)

^b INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

Author keywords

Pharmaceuticals; Sewage system; Wastewater

Indexed keywords

CATCHMENTS; DRUG PRODUCTS; SEWAGE;

ANAEROBIC CONDITIONS; CITALOPRAM; DILTIAZEM; IN-SEWER PROCESS; MUNICIPAL WASTEWATERS; SAMPLING POINTS; SEWAGE SYSTEM; SEWER PIPES; SEWER TRANSFORMATIONS; TARGET COMPOUND;

SEWERS;

AMLODIPINE; ATORVASTATIN; BEZAFIBRATE; CARBAMAZEPINE; CIMETIDINE; CITALOPRAM; CLOPIDOGREL; CODEINE; DICLOFENAC; DILTIAZEM; FUROSEMIDE; GEMFIBROZIL; IBUPROFEN; INDOMETACIN; IRBESARTAN; KETOPROFEN; LORAZEPAM; METOPROLOL; NAPROXEN; PRAVASTATIN; PROPYPHENAZONE; RANITIDINE; SALBUTAMOL; SULFAMETHOXAZOLE; TORASEMIDE; VALSARTAN; VENLAFAXINE; DRUG; SEWAGE; WASTE WATER; WATER POLLUTANT;

ANOXIC CONDITIONS; BIOTRANSFORMATION; CONCENTRATION (COMPOSITION); DRUG; EPIDEMIOLOGY; MICROBIAL ACTIVITY; MUNICIPAL SOLID WASTE; SEWER NETWORK; TRANSFORMATION; WASTEWATER;

ANAEROBIC REACTOR; ARTICLE; BIOLOGICAL ACTIVITY; DRUG INDUSTRY; ENVIRONMENTAL TEMPERATURE; IONIZATION; LIMIT OF QUANTITATION; PHYSICAL CHEMISTRY; PRESSURE; QUANTITATIVE ANALYSIS; SEWER; WASTE WATER; WASTE WATER MANAGEMENT; ANAEROBIC GROWTH; ANALYSIS; ENVIRONMENTAL MONITORING; PROCEDURES; SEWAGE; WATER POLLUTANT;

ANAEROBIOSIS; ENVIRONMENTAL MONITORING; PHARMACEUTICAL PREPARATIONS; SEWAGE; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84908408988     PISSN: 00431354     EISSN: 18792448     Source Type: Journal    
DOI: 10.1016/j.watres.2014.09.033     Document Type: Article

References (51)

1. Baker D.R., Kasprzyk-Hordern B. Critical evaluation of methodology commonly used in sample collection, storage and preparation for the analysis of pharmaceuticals and illicit drugs in surface water and wastewater by solid phase extraction and liquid chromatography-mass spectrometry. J. Chromatogr. A 2011, 1218:8036-8059.
2. Begoña Barroso M., Alonso R.M., Jiménez R.M. Simultaneous determination of torasemide and its major metabolite M5 in human urine by high-performance liquid chromatography-electrochemical detection. J. Chromatogr. Sci. 2001, 39:491-496.
3. Bitton G. Wastewater microbiology. J. Basic Microbiol. 1994, 35. 216-216.
4. Carballa M., Omil F., Ternes T., Lema J.M. Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge. Water Res. 2007, 41:2139-2150.
5. Castiglioni S., Bagnati R., Melis M., Panawennage D., Chiarelli P., Fanelli R., Zuccato E. Identification of cocaine and its metabolites in urban wastewater and comparison with the human excretion profile in urine. Water Res. 2011, 45:5141-5150.
6. Castiglioni S., Bijlsma L., Covaci A., Emke E., Hernández F., Reid M., Ort C., Thomas K.V., van Nuijs A.L.N., de Voogt P., Zuccato E. Evaluation of uncertainties associated with the determination of community drug use through the measurement of sewage drug biomarkers. Environ. Sci. Technol. 2012, 47:1452-1460.
7. Chando T.J., Everett D.W., Kahle A.D., Starrett A.M., Vachharajani N., Shyu W.C., Kripalani K.J., Barbhaiya R.H. Biotransformation of irbesartan in man. Drug Metab. Dispos. 1998, 26:408-417.
8. Daughton C.G. Illicit Drugs in Municipal Sewage, Pharmaceuticals and Care Products in the Environment 2001, 348-364. American Chemical Society.
9. Daughton C.G., Ruhoy I.S. Environmental footprint of pharmaceuticals: the significance of factors beyond direct excretion to sewers. Environ. Toxicol. Chem. 2009, 28:2495-2521.
10. de Graaff M.S., Vieno N.M., Kujawa-Roeleveld K., Zeeman G., Temmink H., Buisman C.J.N. Fate of hormones and pharmaceuticals during combined anaerobic treatment and nitrogen removal by partial nitritation-anammox in vacuum collected black water. Water Res. 2011, 45:375-383.
11. Eggen R.I.L., Hollender J., Joss A., Schärer M., Stamm C. Reducing the discharge of micropollutants in the aquatic environment: the benefits of upgrading wastewater treatment plants. Environ. Sci. Technol. 2014, 48.
12. Ericson J.F. An evaluation of the OECD 308 water/sediment systems for investigating the biodegradation of pharmaceuticals. Environ. Sci. Technol. 2007, 41:5803-5811.
13. Ferrando-Climent L., Collado N., Buttiglieri G., Gros M., Rodriguez-Roda I., Rodriguez-Mozaz S., Barceló D. Comprehensive study of ibuprofen and its metabolites in activated sludge batch experiments and aquatic environment. Sci. Total Environ. 2012, 438:404-413.
14. Gobel A., Thomsen A., McArdell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ. Sci. Technol. 2005, 39:3981-3989.
15. Gros M., Rodríguez-Mozaz S., Barceló D. Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J. Chromatogr. A 2012, 1248:104-121.
16. Guisasola A., de Haas D., Keller J., Yuan Z. Methane formation in sewer systems. Water Res. 2008, 42:1421-1430.
17. Gutierrez O., Park D., Sharma K.R., Yuan Z. Effects of long-term pH elevation on the sulfate-reducing and methanogenic activities of anaerobic sewer biofilms. Water Res. 2009, 43:2549-2557.
18. Gutierrez O., Park D., Sharma K.R., Yuan Z. Iron salts dosage for sulfide control in sewers induces chemical phosphorus removal during wastewater treatment. Water Res. 2010, 44:3467-3475.
19. Huisman J.L., Gujer W. Modelling wastewater transformation in sewers based on ASM3. Water Sci. Technol. 2002, 45(6):51-60.
20. Hvitved-Jacobsen T. Sewer systems and processes. Sewer Processes - Microbial and Chemical Process Engineering of Sewer Networks 2002, CRC Press, Boca Raton.
21. Hvitved-Jacobsen T., Vollertsen J., Haaning Nielsen A. Sewer Processes: Microbial and Chemical Process Engineering of Sewer Networks 2013, Taylor & Francis Group. second ed.
22. Iwamura A., Fukami T., Hosomi H., Nakajima M., Yokoi T. CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay. Drug Metab. Dispos. 2011, 39:838-846.
23. Jelic A., Gros M., Ginebreda A., Cespedes-Sanchez R., Ventura F., Petrovic M., Barcelo D. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res. 2011, 45:1165-1176.
24. Joss A., Keller E., Alder A.C., Gbel A., McArdell C.S., Ternes T., Siegrist H. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res. 2005, 39:3139.
25. Keller-Lehmann B., Corrie S., Ravn R., Yuan Z., Keller J. Preservation and simultaneous analysis of relevant soluble sulfur species in sewage samples. Proceedings of the Second International IWA Conference on Sewer Operation and Maintenance 2006, 26-28 October, Vienna, Austria.
26. Khan U., Nicell J.A. Refined sewer epidemiology mass balances and their application to heroin, cocaine and ecstasy. Environ. Int. 2011, 37:1236-1252.
27. Kovalova L., Siegrist H., Singer H., Wittmer A., McArdell C.S. Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination. Environ. Sci. Technol. 2012, 46:1536-1545.
28. Kümmerer K. The presence of pharmaceuticals in the environment due to human use - present knowledge and future challenges. J. Environ. Manag. 2009, 90:2354-2366.
29. Lai F.Y., Ort C., Gartner C., Carter S., Prichard J., Kirkbride P., Bruno R., Hall W., Eaglesham G., Mueller J.F. Refining the estimation of illicit drug consumptions from wastewater analysis: co-analysis of prescription pharmaceuticals and uncertainty assessment. Water Res. 2011, 45:4437-4448.
30. Lienert J., Güdel K., Escher B.I. Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environ. Sci. Technol. 2007, 41:4471-4478.
31. Maurer M., Escher B.I., Richle P., Schaffner C., Alder A.C. Elimination of [beta]-blockers in sewage treatment plants. Water Res. 2007, 41:1614-1622.
32. Miège C., Choubert J.M., Ribeiro L., Eusèbe M., Coquery M. Fate of pharmaceuticals and personal care products in wastewater treatment plants - conception of a database and first results. Environ. Pollut. 2009, 157:1721-1726.
33. O'Brien J.W., Thai P.K., Eaglesham G., Ort C., Scheidegger A., Carter S., Lai F.Y., Mueller J.F. A model to estimate the population contributing to the wastewater using samples collected on census day. Environ. Sci. Technol. 2014, 48:517-525.
34. Onesios K., Yu J., Bouwer E. Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review. Biodegradation 2009, 20:441-466.
35. Ort C., Lawrence M.G., Reungoat J., Mueller J.F. Sampling for PPCPs in wastewater systems: comparison of different sampling modes and optimization strategies. Environ. Sci. Technol. 2010, 44:6289-6296.
36. Ort C., Lawrence M.G., Rieckermann J., Joss A. Sampling for Pharmaceuticals and Personal Care Products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? a critical review. Environ. Sci. Technol. 2010, 44:6024-6035.
37. Radjenovic J., Petrovic M., Barceló D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009, 43:831-841.
38. Radke M., Lauwigi C., Heinkele G., Mürdter T.E., Letzel M. Fate of the antibiotic sulfamethoxazole and its two major human metabolites in a water sediment test. Environ. Sci. Technol. 2009, 43:3135-3141.
39. Rudelle E., Vollertsen J., Hvitved-Jacobsen T., Nielsen A.H. Anaerobic transformations of organic matter in collection systems. Water Environ. Res. 2011, 83(6):532-540.
40. Rudy A.C., Knight P.M., Brater D.C., Hall S.D. Stereoselective metabolism of ibuprofen in humans: administration of R-, S- and racemic ibuprofen. J. Pharmacol. Exp. Ther. 1991, 259:1133-1139.
41. Sangkuhl K., Klein T.E., Altman R.B. Clopidogrel pathway. Pharmacogenet. Genom. 2010, 20:463-465.
42. Sundaresan P., Lykos D., Daher A., Diamond T., Morris R., Howes L.G. Comparative effects of glibenclamide and Metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM. Diabetes Care 1997, 20:692-697.
43. Schilperoort R.P.S., Dirksen J., Langeveld J.G., Clemens F.H.L.R. Assessing characteristic time and space scales of in-sewer processes by analysis of one year of continuous in-sewer monitoring data. Water Sci. Technol. 2012, 66(8):1614-1620.
44. Sutherland-Stacey L., Corrie S., Neethling A., Johnson I., Gutierrez O., Dexter R., Yuan Z., Keller J., Hamilton G. Continuous measurement of dissolved sulfide in sewer systems. Water Sci. Technol. 2008, 57:375-381.
45. Thai P.K., Jiang G., Gernjak W., Yuan Z., Lai F.Y., Mueller J.F. Effects of sewer conditions on the degradation of selected illicit drug residues in wastewater. Water Res. 2014, 48:538-547.
46. van der Ven A.J., Vree T.B., van Ewijk-Beneken Kolmer E.W., Koopmans P.P., van der Meer J.W. Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole. Br. J. Clin. Pharmacol. 1995, 39:621-625.
47. van Nuijs A.L.N., Abdellati K., Bervoets L., Blust R., Jorens P.G., Neels H., Covaci A. The stability of illicit drugs and metabolites in wastewater, an important issue for sewage epidemiology?. J. Hazard. Mater. 2012, 239-240:19-23.
48. van Nuijs A.L.N., Castiglioni S., Tarcomnicu I., Postigo C., de Alda M.L., Neels H., Zuccato E., Barcelo D., Covaci A. Illicit drug consumption estimations derived from wastewater analysis: a critical review. Sci. Total Environ. 2011, 409:3564-3577.
49. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment - a review. Sci. Total Environ. 2012, 429:123-155.
50. Weigel S., Berger U., Jensen E., Kallenborn R., Thoresen H., Hühnerfuss H. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 2004, 56:583-592.
51. Weissbrodt D., Kovalova L., Ort C., Pazhepurackel V., Moser R., Hollender J., Siegrist H., McArdell C.S. Mass flows of X-ray contrast media and cytostatics in hospital wastewater. Environ. Sci. Technol. 2009, 43:4810-4817.